Skip to main content

COVID-19

      RT @AkhilSoodMD: Exciting day at #ACR21
      I wrote an article discussing COVID 19 in #RheumatoidArthritis discussing the
      3 years 5 months ago
      Exciting day at #ACR21 I wrote an article discussing COVID 19 in #RheumatoidArthritis discussing the following abstracts 0097 by Hasseli 1445 by @NamrataRheum L04 by @rheum_cat & @rheum_covid @rheumnow #COVID19 #RA #JAK #Rituximab https://t.co/g32ZYHBjQY
      RT @KDAO2011: Dr. Petri noted that 1 week off of immunosuppressants is adequate for most lupus patients to mount a respo
      3 years 5 months ago
      Dr. Petri noted that 1 week off of immunosuppressants is adequate for most lupus patients to mount a response. She avoided RTX during the pandemic. In pts who have had inadequate response to 2 or 3 doses of mRNA, she switches them to J&J. #ACR21 #COVI19 CH @rheumnow https://t.co/qNjmx9uTLF
      RT @KDAO2011: HSS Study of 136 SLE flares post-vax:
      👉100 (74%) w/expected AE (headache/myalgias)
      👉11 (8.1%) pts w
      3 years 5 months ago
      HSS Study of 136 SLE flares post-vax: 👉100 (74%) w/expected AE (headache/myalgias) 👉11 (8.1%) pts with SLE flare 👉Majority of flares were mild-mod & occurred w/in 1 week of vaccination 👉Most resolved w/in 7 days. Abst#0896 #ACR21 @rheumnow https://t.co/e6AP8PPRH2
      RT @Yuz6Yusof: #ACR21 #Abstr0437 OK, so RTX affects #COVID vaccine but some pts need RTX. Factors predicting response to
      3 years 5 months ago
      #ACR21 #Abstr0437 OK, so RTX affects #COVID vaccine but some pts need RTX. Factors predicting response to vaccine: RA vs AAV/IIM Higher IgG Longer time-to-RTX Lower RTX courses Number. Prediction Calculator is developed but need ext. validation #RheumNow https://t.co/iXSaGQ76hS https://t.co/WQAV3GRPBz
      RT @LCalabreseDO: #ACR21 Ignaki Sanz makes the case that +++ AUTOANTIBODIES are integrally involved in #COVID19 immunopa
      3 years 5 months ago
      #ACR21 Ignaki Sanz makes the case that +++ AUTOANTIBODIES are integrally involved in #COVID19 immunopathogeneisis and may rise and fall w disease states- TBD what role they play in acute disease and #LongCovid @CCalabreseDO @VirusesImmunity @CleClinicMD #COVID19AB https://t.co/9dzCSh5V7R
      Opening Day Report
      The opening of ACR2 Convergence was a hit for all who signed up and viewed in. The day included the presidential address by outgoing president Dr. David Karp (UT Southwestern) and a keynote talk and…
      RT @KDAO2011: Dr. P Krause (FDA/CBER Deputy Dir., Office of Vaccine Research and Review) on #COVIDvaccine in kids:
      👉C
      3 years 5 months ago
      Dr. P Krause (FDA/CBER Deputy Dir., Office of Vaccine Research and Review) on #COVIDvaccine in kids: 👉Children respond to vaccine better than adults; can use lower doses 👉the lower dose will mitigate safety concerns (FDA gave EUA for Pfizer vaccine for 5-11 yo) #ACR21 https://t.co/Z7kcYQKZ8S
      RT @KDAO2011: 👉 anti-CK Ab may be a cause of #LongCovid syndrome
      👉found in patients with autoimmune (SLE/Sjogrens)
      3 years 5 months ago
      👉 anti-CK Ab may be a cause of #LongCovid syndrome 👉found in patients with autoimmune (SLE/Sjogrens) and can affect dz severity. 👉has not been seen in children 2/2 #ACR21
      ×